TFS International Appoints Dr Suzanne Pavon as Executive Vice President, Quality Assurance

TFS logo

Lund, Sweden, June 20, 2018 / B3C newswire / -- TFS International is delighted to announce that Dr Suzanne Pavon has accepted the position of Executive Vice President, Quality Assurance.  Dr Pavon is an entrepreneurial, quality focused, senior executive with over 20 years’ global experience in the CRO, biotechnology and pharmaceutical industries.

Her most recent role was with Piramal Critical Care (PCC), the third largest producer of inhaled anesthetics and a global player in hospital generics.  She held the executive position of Global Quality Director, across PCC manufacturing sites and global offices, and was responsible for the quality management and compliance in more than 113 countries and 83 business partners.

“We are delighted to welcome Suzanne into our TFS family where she will lead our quality assurance and compliance activities,” said Dr János Filakovský, Chief Executive Officer.  “Suzanne has over 20 years’ experience in global, cross-functional, cross-geographic Biopharmaceutical Product Development.  She brings with her a dynamism and leadership style that will have a significantly positive impact at TFS.”

The majority of Suzanne’s experience has been in international roles and she has lived and worked in the US, Canada, Jordan, UK, Belgium, France and the Netherlands. She has managed diverse cultural teams and is extremely proud of her record of achievement in quality improvement, team development, simplification of processes and business growth. Suzanne has proven leadership skills with an ability to manage quality and compliance through significant change, whilst achieving key quality and business performance targets.

Suzanne said of her new role, “I am extremely thrilled to be joining TFS International, one of the leading, mid-sized global CROs.  I will be responsible to safeguard the company’s compliance and risk and will be committed to ensuring the highest quality in our services and projects whilst having patients and customers in mind.
I am passionate about combining business strategy and quality mindset, talent development, simplification, operational and quality excellence to be a leading differentiator in our business.
I was inspired from the moment I met the TFS Board, János and the Executive Committee, and they made me want to become part of this highly professional and dynamic team, and the exciting journey they have started."

Dr Pavon will be based out of the TFS offices in London.

 
About TFS International
TFS International is a leading, mid-size clinical Contract Research Organization providing global clinical development solutions. Founded in 1996 in Sweden, TFS currently operates in 21 countries throughout Europe and North America and employs more than 700 professionals. TFS’ core therapeutic areas of expertise are oncology, dermatology, ophthalmology, immunology, cardiology, CNS and endocrinology. Through two business areas, TFS Develop™ and TFS People™, TFS provides end-to-end solutions and tactical functional services throughout the world.


Contact

TFS International
Andy Waiton
Director Marketing & Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.tfscro.com

 

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
Ok